🔗 Permalink

Inventor profile of:

Ulrich Moebius

City:

Gauting

Country:

Germany

Published Applications:

7

Last publication date:

2024-03-28

Top Assignees for applications by Ulrich Moebius

The entities that hold a legal rights for patent applications filed by inventor Moebius Ulrich:

MediGene AG 2 MARTINSRIED, Germany
Deutsches Krebsforschungszentrum Stiftung des offentlichen Rechts 1 Heidelberg, Germany
Pieris Pharmaceuticals GmbH 1 Freising-Weihenstephan, Germany
PIERIS PHARMACEUTICALS GMBH 1 Hallbergmoos, Germany
Deutsches Krebsforschungszentrum Stiftung des Oeffentlichen Rechts 1 HEIDELBERG, Germany
SOTIO BIOTECH A.S. 1 Prague, Czech Republic
DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFUNG DES OFFENTLICHEN RECHTS 1 Heidelberg, Germany

Recent patent applications by Moebius Ulrich

Ulrich Moebius from Gauting, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-03-28

US20240100180A1

Human necessities

TUMOR-SPECIFIC CLAUDIN 18.2 ANTIBODY-DRUG CONJUGATES

#2 | 2024-02-01

US20240034783A1

Chemistry; metallurgy

TUMOR-SPECIFIC CLAUDIN 18.2 ANTIBODIES

#3 | 2023-02-02

US20230030674A1

Chemistry; metallurgy

HUMANIZED CLDN18.2 ANTIBODIES

#4 | 2021-07-01

US20210198380A1

Chemistry; metallurgy

ANTI-CANCER FUSION POLYPEPTIDE

#5 | 2019-01-10

US20190010248A1

Chemistry; metallurgy

Anti-cancer fusion polypeptide

#6 | 2014-05-01

US20140120117A1

Chemistry; metallurgy

Treatment of tumors using specific anti-L1 antibody

#7 | 2012-10-11

US20120258039A1

Chemistry; metallurgy

Treatment of tumors using specific anti-L1 antibody

InventorID:

744960 ⎘